Literature DB >> 27342388

Deferasirox in thalassemia patients with end-stage renal disease.

Hassan G Beydoun1, Antoine N Saliba2, Ali T Taher3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27342388     DOI： 10.1002/ajh.24457

Source DB:  PubMed          Journal:  Am J Hematol        ISSN： 0361-8609            Impact factor:   10.047


× No keyword cloud information.
  1 in total

1.  Iron Chelation Therapy With Deferasirox in Sickle Cell Disease With End-Stage Renal Disease.

Authors:  Ashok Raj; Kerry McGowan; Esther Knapp; Jun Zhao; Siddharth Shah
Journal:  Cureus       Date:  2022-04-14
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.